These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27832096)

  • 21. MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer.
    Hasumi M; Suzuki K; Oya N; Ito K; Kurokawa K; Fukabori Y; Yamanaka H
    Anticancer Res; 2002; 22(2B):1205-8. PubMed ID: 12168926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
    Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
    Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.
    Kumar R; Kumar M; Jagannathan NR; Gupta NP; Hemal AK
    Urol Res; 2004 Feb; 32(1):36-40. PubMed ID: 14534764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.
    Scheenen TW; Gambarota G; Weiland E; Klomp DW; Fütterer JJ; Barentsz JO; Heerschap A
    Magn Reson Med; 2005 Jun; 53(6):1268-74. PubMed ID: 15906304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).
    Tiwari P; Rosen M; Madabhushi A
    Med Phys; 2009 Sep; 36(9):3927-39. PubMed ID: 19810465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue.
    Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; de la Rosette JJ; Oosterhof GO; Ruijter ET; Ruijs SH
    Anticancer Res; 1997; 17(3A):1455-60. PubMed ID: 9179183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.
    Brame RS; Zaider M; Zakian KL; Koutcher JA; Shukla-Dave A; Reuter VE; Zelefsky MJ; Scardino PT; Hricak H
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):110-4. PubMed ID: 18990509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis.
    Pels P; Ozturk-Isik E; Swanson MG; Vanhamme L; Kurhanewicz J; Nelson SJ; Van Huffel S
    NMR Biomed; 2006 Apr; 19(2):188-97. PubMed ID: 16411280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
    Weis J; von Below C; Tolf A; Ortiz-Nieto F; Wassberg C; Häggman M; Ladjevardi S; Ahlström H
    J Magn Reson Imaging; 2017 Apr; 45(4):1232-1240. PubMed ID: 27556571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
    Thörmer G; Otto J; Horn LC; Garnov N; Do M; Franz T; Stolzenburg JU; Moche M; Kahn T; Busse H
    Acta Radiol; 2015 Jan; 56(1):121-8. PubMed ID: 24504488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidimensional MR spectroscopic imaging of prostate cancer in vivo.
    Thomas MA; Nagarajan R; Huda A; Margolis D; Sarma MK; Sheng K; Reiter RE; Raman SS
    NMR Biomed; 2014 Jan; 27(1):53-66. PubMed ID: 23904127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2D JPRESS of human prostates using an endorectal receiver coil.
    Yue K; Marumoto A; Binesh N; Thomas MA
    Magn Reson Med; 2002 Jun; 47(6):1059-64. PubMed ID: 12111951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence.
    Tayari N; Steinseifer IK; Selnæs KM; Bathen TF; Maas MC; Heerschap A
    Invest Radiol; 2017 Oct; 52(10):640-646. PubMed ID: 28632688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence.
    Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; Ruijs SH
    Magn Reson Med; 1997 Feb; 37(2):204-13. PubMed ID: 9001144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
    Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B
    Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil.
    Kim JK; Kim DY; Lee YH; Sung NK; Chung DS; Kim OD; Kim KB
    Magn Reson Imaging; 1998 Dec; 16(10):1281-8. PubMed ID: 9858286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization.
    Zakian KL; Shukla-Dave A; Ackerstaff E; Hricak H; Koutcher JA
    Cancer Biomark; 2008; 4(4-5):263-76. PubMed ID: 18957715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic characterization of human prostate tissue with proton MR spectroscopy.
    Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C
    Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.